Research Work: In 2011, I was awarded a national invention patent for "A Prenatal Screening Kit for Trisomy 21 Syndrome" as the primary inventor. In 2019, I led the General Program of the National Natural Science Foundation of China (NSFC) titled "Study on the Reactive Oxygen Species-Related Mechanisms of Autoimmune Thyroiditis in Infertile Patients with Endometriosis." Also in 2019, I led the National Key Research and Development Program titled "Big Data Quality Control for Major Birth Defects and Construction of an Assisted Reproductive Health Database." In 2022, I led another General Program of the NSFC titled "Study on the Mechanisms of Vitamin D Regulating the AMH Pathway to Improve Follicular Development Dysfunction in Polycystic Ovary Syndrome." Additionally, I participated in the completion of 6 projects funded by the NSFC and the Ministry of Education. I have published over 60 papers in core domestic and international journals, including 33 SCI-indexed papers. As a co-first author, I published a large-scale randomized clinical controlled trial in JAMA (Impact Factor = 44.405) in December 2017: "Pregnancy Outcomes in Women with Normal Thyroid Function and Thyroid Autoimmunity Receiving Levothyroxine Treatment." Awards: In 2011, I was awarded a national invention patent for "A Prenatal Screening Kit for Trisomy 21 Syndrome" as the primary inventor. In 2015, I received the First Prize of the Science and Technology Progress Award from the Ministry of Education for "Clinical Research on the Diagnosis and Treatment of Refractory Infertility." In 2017, I received the Peking University Outstanding SCI Paper Award. In 2017, I received the Peking University Third Hospital Outstanding SCI Paper Award.